We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Pooyan Kazemian PhD

Pooyan Kazemian PhD

Assistant Professor of Operations Management, Weatherhead School of Management, Case Western Reserve University, Cleveland, Ohio

Pooyan Kazemian is an Assistant Professor of Operations at Case Western Reserve University’s Weatherhead School of Management. Pooyan’s research leverages Operations Research, Machine Learning, and Artificial Intelligence methods to solve pressing problems in the areas of healthcare operations management, medical decision-making, and health policy. His research aims to improve access to care, quality of care, and patient outcomes at a lower cost.

Disclosures

Dr. Kazemian has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Expanding Access to Newer Type 2 Diabetes Medications in Low- and Middle-Income Countries
  2. Predicting 5- and 10-Year Mortality Risk in Older Adults With Diabetes
  3. Disparities in Glycemic Control, Monitoring, and Treatment of Type 2 Diabetes in England
  4. Examining the Economic Implications of the EMPA-REG OUTCOME Trial
  5. FDA Added-Sugar Labeling Policy Cost-Effective and Expected to Improve Health
  6. Prediction of Individual Life-Years Gained Without Cardiovascular Events From Preventive Treatment in Patients With Type 2 Diabetes Mellitus
  7. 30-Year Cost-Effectiveness Associated With Excellent Glycemic Control in Type 1 Diabetes
  8. Clinical, Quality-of-Life, and Cost Associated With Glycemic Control in Type 1 Diabetes

Most Read This Week

Recently Updated